Fu-peng Liu
Jining Medical University
Internal medicineSurgeryOdds ratioRandomized controlled trialProspective cohort studyClinical endpointAmputationType 2 diabetesInsulinCritical limb ischemiaTransplantationIndependent predictorRemission rateNewly diagnosedPremixed insulinIncidence (epidemiology)Clinical trialDiabetes mellitusMedicine
Publications 2
#1Fu-peng Liu (Jining Medical University)H-Index: 1
Last. Lin Liao (SDU: Shandong University)H-Index: 12
view all 8 authors...
: The aim of the study was to evaluate the remission rate with short-term premixed insulin therapy in newly diagnosed type 2 diabetes outpatients and investigate predictors contributing to the remission rate. A 5-year prospective study was conducted with a total of 170 patients enrolled. Patients were treated with premixed insulin monotherapy or insulin in combination with one or two oral drugs. After glucose levels were well controlled, insulin and oral drugs were discontinued in a stepwise man...
#1Fu-peng LiuH-Index: 1
#2Jianjun DongH-Index: 11
Last. Lin LiaoH-Index: 12
view all 11 authors...
Background Amputation-free survival (AFS) has been recommended as the gold standard for evaluating No-Option Critical Limb Ischemia (NO-CLI) therapy.Early-phase clinical trials suggest that autologous bone-marrow derived cells (BMCs) transplantation may have a positive effect on patients with NO-CLI,especially decreasing the incidence of amputation.However,the BMCs therapeutic efficacy remains controversial and whether BMCs therapy is suitable for all CLI patients is unclear.Methods We conducted...
16 Citations